Gorbach T, Carpenter J, Frost C, Josefsson M, Nicholas J, Nyberg L
Stat Med. 2025; 44(6):e70040.
PMID: 40079649
PMC: 11905689.
DOI: 10.1002/sim.70040.
Martin G, Pate A, Bladon S, Sperrin M, Riley R
BMC Med. 2025; 23(1):142.
PMID: 40050803
PMC: 11887178.
DOI: 10.1186/s12916-025-03978-3.
Lin G, Wei Y, Guo Z, Wang H, Chan K, Chan R
Respir Res. 2025; 26(1):75.
PMID: 40022135
PMC: 11871785.
DOI: 10.1186/s12931-025-03156-2.
Baneshi M, Mishra G, Dobson A
BMJ Public Health. 2025; 2(2):e000963.
PMID: 40018552
PMC: 11816716.
DOI: 10.1136/bmjph-2024-000963.
Wallace M, Mussino E, Aradhya S, Harber-Aschan L, Wilson B
BMJ Public Health. 2025; 2(1):e000643.
PMID: 40018167
PMC: 11812831.
DOI: 10.1136/bmjph-2023-000643.
Urinary Catecholamines Predict Relapse During Complete Remission in High-Risk Neuroblastoma.
Matser Y, Samim A, Fiocco M, van de Mheen M, van der Ham M, de Sain-van der Velden M
JCO Precis Oncol. 2025; 9:e2400491.
PMID: 39983076
PMC: 11867808.
DOI: 10.1200/PO-24-00491.
Letter in reply to: Enhancing the understanding of anti-VEGF treatment failure in retinal vascular diseases: a call for expanded analyses and threshold validation.
Fu D, Sivaprasad S, Faes L
Eye (Lond). 2025; .
PMID: 39972200
DOI: 10.1038/s41433-025-03681-w.
Parametric Estimation of the Mean Number of Events in the Presence of Competing Risks.
Entrop J, Jakobsen L, Crowther M, Clements M, Eloranta S, Dietrich C
Biom J. 2025; 67(1):e70038.
PMID: 39967277
PMC: 11836554.
DOI: 10.1002/bimj.70038.
Correlation of cumulative fasting blood glucose exposure with gastrointestinal cancers: A prospective cohort study.
Liu K, Wang W, Liu Y, Li J, Ma C, Tian Y
Medicine (Baltimore). 2025; 104(7):e41529.
PMID: 39960953
PMC: 11835132.
DOI: 10.1097/MD.0000000000041529.
Analysis of the dynamics of transition from non-colonization to colonization and bacteremia in hemodialysis patients using Markov models.
Montoya-Urrego D, Vanegas J, Jimenez J, Gonzalez-Gomez D
F1000Res. 2025; 13:837.
PMID: 39931330
PMC: 11809629.
DOI: 10.12688/f1000research.151896.1.
Inverse Probability of Treatment Weighting Using the Propensity Score With Competing Risks in Survival Analysis.
Austin P, Fine J
Stat Med. 2025; 44(5):e70009.
PMID: 39915951
PMC: 11803134.
DOI: 10.1002/sim.70009.
Premorbid predictors of death at initial presentation of coronary heart disease in the Women's Health Initiative study.
Chen M, Li J, Iyer K, Tcheandjieu C, Jimenez S, Salfati E
Am J Prev Cardiol. 2025; 21:100931.
PMID: 39911229
PMC: 11795550.
DOI: 10.1016/j.ajpc.2025.100931.
Revealing the limitations of 10-year MACE observations: 20-year observed total cardiovascular burden in the EPIC-Norfolk study.
van Trier T, Snaterse M, Dorresteijn J, Bogaart M, Scholte Op Reimer W, Visseren F
Open Heart. 2025; 12(1).
PMID: 39904556
PMC: 11795405.
DOI: 10.1136/openhrt-2024-002981.
Association of accelerated phenotypic aging, genetic risk, and lifestyle with progression of type 2 diabetes: a prospective study using multi-state model.
Pan L, Liu Y, Huang C, Huang Y, Lin R, Wei K
BMC Med. 2025; 23(1):62.
PMID: 39901253
PMC: 11792689.
DOI: 10.1186/s12916-024-03832-y.
Cancer incidence and competing mortality risk following 15 presenting symptoms in primary care: a population-based cohort study using electronic healthcare records.
Barclay M, Renzi C, Harrison H, Torralbo A, White B, Ip S
BMJ Oncol. 2025; 3(1):e000500.
PMID: 39886176
PMC: 11660325.
DOI: 10.1136/bmjonc-2024-000500.
A Bayesian Joint Model of Multiple Nonlinear Longitudinal and Competing Risks Outcomes for Dynamic Prediction in Multiple Myeloma: Joint Estimation and Corrected Two-Stage Approaches.
Alvares D, Barrett J, Mercier F, Roumpanis S, Yiu S, Castro F
Stat Med. 2025; 44(3-4):e10322.
PMID: 39865588
PMC: 11771571.
DOI: 10.1002/sim.10322.
DIAMACC: protocol of a prospective diagnostic accuracy study of the maximal systolic acceleration to detect peripheral arterial disease in patients with diabetes-related foot ulceration in the Netherlands.
Willems S, Schepers A, Hamming J, Brouwers J
BMJ Open. 2025; 14(12):e086629.
PMID: 39806662
PMC: 11667405.
DOI: 10.1136/bmjopen-2024-086629.
Kidney Outcomes with Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes and Moderate Cardiovascular Risk.
Neumiller J, Herrin J, Swarna K, Polley E, Galindo R, Umpierrez G
Clin J Am Soc Nephrol. 2024; .
PMID: 39729347
PMC: 11835155.
DOI: 10.2215/CJN.0000000587.
The association between maternal smoking during pregnancy and multimorbidity of non-communicable chronic diseases trajectory in offspring.
Wang H, Sun X, Wang Z, Liu H, Huang J, Tang Y
BMC Public Health. 2024; 24(1):3282.
PMID: 39592985
PMC: 11590617.
DOI: 10.1186/s12889-024-20686-4.
A Multistate Model Incorporating Relative Survival Extrapolation and Mixed Time Scales for Health Technology Assessment.
Chen E, Dickman P, Clements M
Pharmacoeconomics. 2024; 43(3):297-310.
PMID: 39586963
PMC: 11825556.
DOI: 10.1007/s40273-024-01457-w.